Thrombo-Go, manufactured by BIOAXA, provides a trusted solution for anticoagulation therapy. This Enoxaparin Sodium Injection IP contains 40 mg in a 0.4 mL pre-filled syringe, designed for subcutaneous use. Specifically, it helps prevent and treat blood clots in patients at risk of deep vein thrombosis (DVT), pulmonary embolism (PE), or those undergoing certain surgeries. Each syringe offers a precise dose, making it a convenient choice for healthcare settings.
Thrombo-Go effectively prevents and treats blood clotting issues in adults under the following conditions:
- Patients at risk of deep vein thrombosis (DVT) or pulmonary embolism (PE), especially after surgery.
- Individuals with acute coronary syndrome, such as unstable angina or heart attacks.
- Those requiring anticoagulation during orthopedic surgeries, like hip or knee replacements.
How to Use Thrombo-Go
Healthcare professionals administer Thrombo-Go subcutaneously, typically in the abdomen or thigh. First, they determine the dose based on the patient’s weight, medical condition, and clotting risk. For DVT prevention, doctors often prescribe 40 mg once daily, while treatment doses may range from 1 mg/kg to 1.5 mg/kg daily. After administration, patients may need monitoring for bleeding risks or signs of low platelet counts.
Key Features and Benefits
- Effective Clot Prevention: Thrombo-Go reduces the risk of blood clots, protecting patients from serious conditions like DVT or PE.
- Pre-Filled Syringe: The 40 mg/0.4 mL syringe ensures accurate dosing, saving time in clinical settings.
- Versatile Use: It works well for both prevention and treatment of clotting disorders in various medical scenarios.
Storage Instructions
Store Thrombo-Go at 20°C to 25°C (68°F to 77°F). You can allow brief temperature changes between 15°C to 30°C (59°F to 86°F). However, never freeze the product to maintain its stability and effectiveness.
Important Safety Information
While Thrombo-Go is highly effective, it comes with some precautions:
- Bleeding Risks: Enoxaparin increases the risk of bleeding. Therefore, doctors monitor patients closely for signs of excessive bleeding, such as bruising or nosebleeds.
- Side Effects: Some patients may experience mild side effects like injection site reactions, pain, or swelling. Rarely, serious effects like low platelet counts (thrombocytopenia) or spinal hematoma may occur.
- Contraindications: Avoid using Thrombo-Go if you have a known allergy to enoxaparin, a history of heparin-induced thrombocytopenia (HIT), or active major bleeding.
Why Choose Thrombo-Go?
Thrombo-Go stands out as a trusted choice for anticoagulation therapy. Its pre-filled syringe design ensures precise dosing, making it a go-to option for healthcare providers managing clotting risks. Moreover, the product’s clear packaging and detailed labeling help professionals quickly identify the correct dosage, ensuring safe and efficient use in clinical settings.
For pharmacies and healthcare facilities, Thrombo-Go offers a dependable option to support patients requiring anticoagulation therapy. Ensure proper administration by trained professionals to maximize safety and effectiveness.
Key Points
Aspect | Details |
---|---|
Product | Thrombo-Go (Enoxaparin Sodium Injection IP) |
Strength | 40 mg/0.4 mL |
Indication | Prevents and treats blood clots in adults |
Administration | Subcutaneous use by healthcare professionals |
Dosage | 1 mg/kg to 1.5 mg/kg daily for treatment; 40 mg daily for prevention |
Warnings | Risk of bleeding; monitor for signs of excessive bleeding |
Common Side Effects | Injection site reactions, pain, swelling |
Reviews
There are no reviews yet.